Hosted on MSN20d
Gyre Therapeutics president Ma Songjiang sells $42,480 in stockS AN DIEGO—Ma Songjiang, the President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), recently sold a portion of his holdings in the company. The stock has shown strong momentum with a 13.62% gain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback